These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Migraine. Pharmacologic commentary on drugs for the treatment of migraine]. Ziegler A Med Monatsschr Pharm; 1987 May; 10(5):139-52. PubMed ID: 3600490 [No Abstract] [Full Text] [Related]
3. New anti-migraine drugs: present and beyond the millennium. Limmroth V; Diener HC Int J Clin Pract; 1998; 52(8):566-70. PubMed ID: 10622056 [TBL] [Abstract][Full Text] [Related]
4. Contemporary management of migraine, Part 1. Beckett BE Am Pharm; 1990 Mar; NS30(3):51-6. PubMed ID: 2180264 [TBL] [Abstract][Full Text] [Related]
5. Treatment of migraine: a new era. Hoffert MJ Am Fam Physician; 1994 Feb; 49(3):633-8, 643-4. PubMed ID: 8310969 [TBL] [Abstract][Full Text] [Related]
6. [Treatments of migraine]. Lucas C; Valade D Rev Prat; 2008 Mar; 58(6):625-37. PubMed ID: 18437951 [TBL] [Abstract][Full Text] [Related]
7. Treatment of migraine with prophylactic drugs. Evers S Expert Opin Pharmacother; 2008 Oct; 9(15):2565-73. PubMed ID: 18803445 [TBL] [Abstract][Full Text] [Related]
8. [Treatment of migraine]. Hoffmann J; Reuter U Dtsch Med Wochenschr; 2007 Oct; 132(41):2153-8. PubMed ID: 17924297 [TBL] [Abstract][Full Text] [Related]
9. Migraine prophylaxis. Stark RJ; Stark CD Med J Aust; 2008 Sep; 189(5):283-8. PubMed ID: 18759728 [TBL] [Abstract][Full Text] [Related]
11. [Possible mechanisms of the action of drugs for hemicrania]. Di Stasio E; Marano E; Bonuso S; Arcamone P; Buscaino GA Acta Neurol (Napoli); 1990 Aug; 12(4):311-24. PubMed ID: 2251959 [TBL] [Abstract][Full Text] [Related]
12. [Current pharmacotherapy in migraine]. Csépány É; Magyar M; Gyüre T; Bozsik G; Ertsey C Neuropsychopharmacol Hung; 2015 Dec; 17(4):169-76. PubMed ID: 26727720 [TBL] [Abstract][Full Text] [Related]
13. New migraine drugs. Harv Womens Health Watch; 1999 Feb; 6(6):7. PubMed ID: 9973892 [No Abstract] [Full Text] [Related]
14. The pathophysiological and pharmacological basis of current drug treatment of migraine headache. Reddy DS Expert Rev Clin Pharmacol; 2013 May; 6(3):271-88. PubMed ID: 23656340 [TBL] [Abstract][Full Text] [Related]
16. Psychotropic drugs and migraine. Noone JF J Int Med Res; 1977; 5(1 Suppl):66-71. PubMed ID: 863092 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic strategies in migraine patients with mood and anxiety disorders: physiopathological basis. Casucci G; Villani V; Finocchi C Neurol Sci; 2010 Jun; 31 Suppl 1():S99-101. PubMed ID: 20464595 [TBL] [Abstract][Full Text] [Related]
18. CGRP antagonists for decreasing migraine frequency: New options, long overdue. Bucklan J; Ahmed Z Cleve Clin J Med; 2020 Apr; 87(4):211-218. PubMed ID: 32238376 [TBL] [Abstract][Full Text] [Related]
19. Guidelines for controlled trials of drugs in migraine. First edition. International Headache Society Committee on Clinical Trials in Migraine. Cephalalgia; 1991 Feb; 11(1):1-12. PubMed ID: 2036663 [No Abstract] [Full Text] [Related]
20. Sumatriptan: a decade of use and experience in the treatment of migraine. Sheftell FD; Bigal ME; Tepper SJ; Rapoport AM Expert Rev Neurother; 2004 Mar; 4(2):199-209. PubMed ID: 15853561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]